Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 1

1(33.3%)

3Total

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05691179Unknown

COVID-19 Infection and Idiopathic Membranous Nephropathy

Role: collaborator

NCT05435872Not ApplicableUnknown

Gastrointestinal Endoscopy Artificial Intelligence Cloud Platform in Gastrointestinal Endoscopy Screening

Role: collaborator

NCT04958447Unknown

Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China

Role: collaborator

NCT03184896Unknown

Services Mapping Among Older Adults With Hip Fracture

Role: collaborator

NCT03170830Not ApplicableUnknown

Diagnostic Value of CircRNA-Uck2 for Acute Myocardial Infarction

Role: collaborator

NCT02367248Phase 1Unknown

Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage

Role: collaborator

NCT02350010Unknown

Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing

Role: collaborator

All 7 trials loaded